Arbutus Biopharma Corporation (ABUS) Buy or Sell Stock Guide

Last Tuesday

Are you looking for the analysis of Arbutus Biopharma Corporation (ABUS) stock? Are you wondering what the bulls and the bears say about it?

If so, you came to the right place. In this stock guide, we will share with you 2 reasons to buy and 3 reasons to sell ABUS stock. You’ll get a perspective on what the bulls and the bears say about it.

The analysis below may be also helpful to you if you have any of the following questions about ABUS stock:

  • Is ABUS a buy or a sell?
  • Should I sell or hold ABUS stock today?
  • Is ABUS a good buy / investment?
  • What are ABUS analyst opinions, recommendations and ratings?

Let’s start with the bull case. Here are the reasons to buy ABUS stock:

1. ABUS average analyst rating is Buy. See ABUS analyst rating chart.

2. ABUS average analyst price target ($1.63) is above its current price ($1.44). See ABUS price target chart.

Now that you understand the bull case, let’s look at the reasons to sell ABUS stock (i.e., the bear case):

1. ABUS quarterly revenue growth was -47.50%, lower than the industry and sector average revenue growth (1.80% and 2.50%, respectively). See ABUS revenue growth chart.

2. ABUS profitability is declining. The YoY profit margin change was -332.12 percentage points. See ABUS profitability chart.

3. ABUS short interest (days to cover the shorts) ratio is 3.55. The stock garners more short interest than the average industry, sector or S&P 500 stock. See ABUS short interest ratio chart.

Now let's look at the key statistics for ABUS:

Metrics ABUS
Price $1.52
Average Price Target / Upside $1.63 / 7.24%
Average Analyst Rating Hold
Industry Biotechnology
Sector Healthcare
Number of Employees 80
Market Cap $89.33M
Forward P/E Ratio -1.08
Price/Book Ratio 14.71
Revenue (TTM) $6.07M
YoY Quarterly Revenue Growth 92.9%
Profit Margin N/A

What are your thoughts on ABUS?

If you liked this analysis, check out Buy or Sell Stock Guides for other stocks.

Follow Us